Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Epidemiological surveillance of schistosomiasis outbreak in Corsica (France): Are animal reservoir hosts implicated in local transmission?

Oleaga A, Rey O, Polack B, Grech-Angelini S, Quilichini Y, Pérez-Sánchez R, Boireau P, Mulero S, Brunet A, Rognon A, Vallée I, Kincaid-Smith J, Allienne JF, Boissier J.

PLoS Negl Trop Dis. 2019 Jun 24;13(6):e0007543. doi: 10.1371/journal.pntd.0007543. eCollection 2019 Jun.

2.

Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate.

Zannoni J, Mauz N, Seyve L, Meunier M, Pernet-Gallay K, Brault J, Jouzier C, Laurin D, Pezet M, Pernollet M, Cahn JY, Cognasse F, Polack B, Park S.

Blood Adv. 2019 Jun 25;3(12):1868-1880. doi: 10.1182/bloodadvances.2018026955.

3.

Molecular characterization of zoonotic Cryptosporidium spp. and Giardia duodenalis pathogens in Algerian sheep.

Sahraoui L, Thomas M, Chevillot A, Mammeri M, Polack B, Vallée I, Follet J, Ain-Baaziz H, Adjou KT.

Vet Parasitol Reg Stud Reports. 2019 Apr;16:100280. doi: 10.1016/j.vprsr.2019.100280. Epub 2019 Mar 2.

PMID:
31027593
4.

Cryptosporidium parvum-Infected Neonatal Mice Show Gut Microbiota Remodelling Using High-Throughput Sequencing Analysis: Preliminary Results.

Mammeri M, Chevillot A, Thomas M, Julien C, Auclair E, Pollet T, Polack B, Vallée I, Adjou KT.

Acta Parasitol. 2019 Jun;64(2):268-275. doi: 10.2478/s11686-019-00044-w. Epub 2019 Mar 26.

PMID:
30915719
5.

Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.

Mammeri M, Chevillot A, Thomas M, Polack B, Julien C, Marden JP, Auclair E, Vallée I, Adjou KT.

Exp Parasitol. 2018 Nov;194:1-8. doi: 10.1016/j.exppara.2018.09.003. Epub 2018 Sep 17.

PMID:
30237052
6.

Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study.

Resseguier N, Rosso-Delsemme N, Beltran Anzola A, Baumstarck K, Milien V, Ardillon L, Bayart S, Berger C, Bertrand MA, Biron-Andreani C, Borel-Derlon A, Castet S, Chamouni P, Claeyssens Donadel S, De Raucourt E, Desprez D, Falaise C, Frotscher B, Gay V, Goudemand J, Gruel Y, Guillet B, Harroche A, Hassoun A, Huguenin Y, Lambert T, Lebreton A, Lienhart A, Martin M, Meunier S, Monpoux F, Mourey G, Negrier C, Nguyen P, Nyombe P, Oudot C, Pan-Petesch B, Polack B, Rafowicz A, Rauch A, Rivaud D, Schneider P, Spiegel A, Stoven C, Tardy B, Trossaërt M, Valentin JB, Vanderbecken S, Volot F, Voyer-Ebrard A, Wibaut B, Leroy T, Sannie T, Chambost H, Auquier P.

BMJ Open. 2018 Jul 25;8(7):e022409. doi: 10.1136/bmjopen-2018-022409.

7.

Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.

Jouve T, Marlu R, Malvezzi P, Seyve L, Maurizi J, Carron PL, Polack B, Rostaing L.

Blood Purif. 2018;46(3):239-245. doi: 10.1159/000488928. Epub 2018 Jul 4.

PMID:
29972828
8.

Corrigendum to "Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation" [Thromb. Res. 166 (2018) 113-121].

Marlu R, Malvezzi P, Seyve L, Jouve T, Maurizi J, Defendi F, Carron PL, Christophe M, Le Gouellec A, Polack B, Rostaing L.

Thromb Res. 2018 Nov;171:200. doi: 10.1016/j.thromres.2018.05.033. Epub 2018 Jun 8. No abstract available.

PMID:
29887501
9.

Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.

Marlu R, Malvezzi P, Seyve L, Jouve T, Maurizi J, Defendi F, Carron PL, Christophe M, Le Gouellec A, Polack B, Rostaing L.

Thromb Res. 2018 Jun;166:113-121. doi: 10.1016/j.thromres.2018.04.018. Epub 2018 Apr 20. Erratum in: Thromb Res. 2018 Jun 7;:.

PMID:
29747114
10.

Bile Salt Hydrolase Activities: A Novel Target to Screen Anti-Giardia Lactobacilli?

Allain T, Chaouch S, Thomas M, Travers MA, Valle I, Langella P, Grellier P, Polack B, Florent I, Bermúdez-Humarán LG.

Front Microbiol. 2018 Feb 8;9:89. doi: 10.3389/fmicb.2018.00089. eCollection 2018.

11.

Bile-Salt-Hydrolases from the Probiotic Strain Lactobacillus johnsonii La1 Mediate Anti-giardial Activity in Vitro and in Vivo.

Allain T, Chaouch S, Thomas M, Vallée I, Buret AG, Langella P, Grellier P, Polack B, Bermúdez-Humarán LG, Florent I.

Front Microbiol. 2018 Jan 31;8:2707. doi: 10.3389/fmicb.2017.02707. eCollection 2017.

12.

Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations: comment.

Marlu R, Jouve T, Polack B, Sié P, Mémier V.

J Thromb Haemost. 2018 May;16(5):1017-1019. doi: 10.1111/jth.13981. Epub 2018 Mar 24. No abstract available.

PMID:
29460346
13.

Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes.

Meunier M, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet M, Wang Y, Faure P, Szymanski G, Duployez N, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Park S.

Oncotarget. 2017 Nov 6;8(62):105510-105524. doi: 10.18632/oncotarget.22299. eCollection 2017 Dec 1.

14.

Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma.

Ersayin A, Thomas A, Seyve L, Thielens N, Castellan M, Marlu R, Polack B, Dagher MC.

Haematologica. 2017 Dec;102(12):e483-e485. doi: 10.3324/haematol.2017.174037. Epub 2017 Oct 5. No abstract available.

15.

Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM).

Seyve L, Richarme C, Polack B, Marlu R.

Int J Lab Hematol. 2018 Feb;40(1):84-93. doi: 10.1111/ijlh.12744. Epub 2017 Oct 5.

PMID:
28980758
16.

Targeted release of transcription factors for human cell reprogramming by ZEBRA cell-penetrating peptide.

Caulier B, Berthoin L, Coradin H, Garban F, Dagher MC, Polack B, Toussaint B, Lenormand JL, Laurin D.

Int J Pharm. 2017 Aug 30;529(1-2):65-74. doi: 10.1016/j.ijpharm.2017.06.073. Epub 2017 Jun 21.

PMID:
28647433
17.

Lungworm Eucoleus aerophilus (Capillaria aerophila) infection in a feline immunodeficiency virus-positive cat in France.

Elhamiani Khatat S, Rosenberg D, Benchekroun G, Polack B.

JFMS Open Rep. 2016 Jun 6;2(1):2055116916651649. doi: 10.1177/2055116916651649. eCollection 2016 Jan-Jun.

18.

Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer.

Sheikh A, Polack B, Rodriguez Y, Kuker R.

Mol Imaging Radionucl Ther. 2017 Feb 9;26(Suppl 1):50-65. doi: 10.4274/2017.26.suppl.06.

19.

Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.

Chauchet X, Hannani D, Djebali S, Laurin D, Polack B, Marvel J, Buffat L, Toussaint B, Le Gouëllec A.

Mol Ther Oncolytics. 2016 Dec 14;3:16033. doi: 10.1038/mto.2016.33. eCollection 2016.

20.

Targeted release of transcription factors for cell reprogramming by a natural micro-syringe.

Berthoin L, Toussaint B, Garban F, Le Gouellec A, Caulier B, Polack B, Laurin D.

Int J Pharm. 2016 Nov 20;513(1-2):678-687. doi: 10.1016/j.ijpharm.2016.09.081. Epub 2016 Sep 30.

PMID:
27697633
21.

Inadequate labeling of pork sausages prepared in Corsica causing a trichinellosis outbreak in France.

Ruetsch C, Delaunay P, Armengaud A, Peloux-Petiot F, Dupouy-Camet J, Vallée I, Polack B, Boireau P, Marty P.

Parasite. 2016;23:27. doi: 10.1051/parasite/2016027. Epub 2016 Jun 17.

22.

Influence of Breed Size, Age, Fecal Quality, and Enteropathogen Shedding on Fecal Calprotectin and Immunoglobulin A Concentrations in Puppies During the Weaning Period.

Grellet A, Heilmann RM, Polack B, Feugier A, Boucraut-Baralon C, Grandjean D, Grützner N, Suchodolski JS, Steiner JM, Chastant-Maillard S.

J Vet Intern Med. 2016 Jul;30(4):1056-64. doi: 10.1111/jvim.14255. Epub 2016 Jun 8.

23.

Inversion of hematocrit partition at microfluidic bifurcations.

Shen Z, Coupier G, Kaoui B, Polack B, Harting J, Misbah C, Podgorski T.

Microvasc Res. 2016 May;105:40-6. doi: 10.1016/j.mvr.2015.12.009. Epub 2015 Dec 30.

PMID:
26744089
24.

Efficacy of guar gum-based ronidazole capsules as a treatment for Tritrichomonas foetus infection in cats.

Grellet A, Makhlouf SE, Desquilbet L, Hovhannessian F, Boogaerts C, Dore V, Anthony M, Espana B, Prouillac C, Kirilov P, Polack B, Perrot S.

J Feline Med Surg. 2017 Feb;19(2):177-184. doi: 10.1177/1098612X15621353. Epub 2016 Jul 10.

PMID:
26662037
25.

Nematode dermatitis due to Angiostrongylus vasorum infection in a dog.

Cavana P, Bensignor E, Blot S, Carlus M, Chermette R, Crosaz O, Grimm F, Hurion M, Jeandel A, Polack B.

Vet Dermatol. 2015 Aug;26(4):293-e65. doi: 10.1111/vde.12215. Epub 2015 May 12.

PMID:
25963239
26.

Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.

Sürücü E, Polack BD, Demir Y, Durmuşoğlu M, Ekmekçi S, Sarıoğlu S, Çelik AO, Ada E, İkiz AÖ.

Clin Imaging. 2015 Sep-Oct;39(5):781-6. doi: 10.1016/j.clinimag.2015.02.004. Epub 2015 Feb 12.

PMID:
25721710
27.

EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.

Polack B, Calvez T, Chambost H, Rothschild C, Goudemand J, Claeyssens S, Borel-Derlon A, Bardoulat I, Maurel F, Woronoff-Lemsi MC; EQOFIX Study Group.

Transfusion. 2015 Jul;55(7):1787-97. doi: 10.1111/trf.13016. Epub 2015 Feb 5.

PMID:
25652955
28.

Long-term therapy with bevacizumab in a patient with Glanzmann's thrombasthenia and recurrent digestive bleeding due to gastrointestinal angiodysplastic lesions.

Marlu R, Barthelon J, Durand A, Mathieu N, Barro C, Granger V, Tatu A, Pernod G, Polack B, Bonaz B.

Am J Gastroenterol. 2015 Feb;110(2):352-3. doi: 10.1038/ajg.2014.391. No abstract available.

PMID:
25646919
29.

Ex vivo reversal of the anticoagulant effects of edoxaban - comments on the study by Halim et al.

Marlu R, Polack B, Pernod G.

Thromb Res. 2015 Mar;135(3):571. doi: 10.1016/j.thromres.2015.01.002. Epub 2015 Jan 7. No abstract available.

PMID:
25628140
30.

Risk factors of weaning diarrhea in puppies housed in breeding kennels.

Grellet A, Chastant-Maillard S, Robin C, Feugier A, Boogaerts C, Boucraut-Baralon C, Grandjean D, Polack B.

Prev Vet Med. 2014 Nov 1;117(1):260-5. doi: 10.1016/j.prevetmed.2014.07.016. Epub 2014 Aug 15.

31.

Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing.

Genestet C, Le Gouellec A, Chaker H, Polack B, Guery B, Toussaint B, Stasia MJ.

Free Radic Biol Med. 2014 Aug;73:400-10. doi: 10.1016/j.freeradbiomed.2014.06.003. Epub 2014 Jun 12. Review.

PMID:
24929180
32.

The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules.

Demir Y, Polack BD, Karaman C, Ozdoğan O, Sürücü E, Ayhan S, Akkoçlu A, Ozdemir N.

Nucl Med Commun. 2014 Mar;35(3):260-7. doi: 10.1097/MNM.0000000000000049.

PMID:
24468852
33.

Live-attenuated bacteria as a cancer vaccine vector.

Toussaint B, Chauchet X, Wang Y, Polack B, Le Gouëllec A.

Expert Rev Vaccines. 2013 Oct;12(10):1139-54. doi: 10.1586/14760584.2013.836914. Review.

PMID:
24124876
34.

A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.

Le Gouëllec A, Chauchet X, Laurin D, Aspord C, Verove J, Wang Y, Genestet C, Trocme C, Ahmadi M, Martin S, Broisat A, Cretin F, Ghezzi C, Polack B, Plumas J, Toussaint B.

Mol Ther. 2013 May;21(5):1076-86. doi: 10.1038/mt.2013.41. Epub 2013 Mar 26.

35.

18F FDG PET/CT in a child with gliomatosis cerebri.

Sürücü E, Mutafoğlu K, Ince D, Cakmakçı H, Demiral A, Polack BD.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):273-4. doi: 10.1016/j.remn.2012.08.005. Epub 2012 Oct 31. No abstract available.

PMID:
23122744
36.

HDAC6 controls the kinetics of platelet activation.

Sadoul K, Wang J, Diagouraga B, Vitte AL, Buchou T, Rossini T, Polack B, Xi X, Matthias P, Khochbin S.

Blood. 2012 Nov 15;120(20):4215-8. doi: 10.1182/blood-2012-05-428011. Epub 2012 Sep 6.

37.

Atypical hyperpachymorph Trypanosoma (Nannomonas) congolense forest-type in a dog returning from Senegal.

Desquesnes M, Ravel S, Deschamps JY, Polack B, Roux F.

Parasite. 2012 Aug;19(3):239-47.

38.

Bacterial vectors for active immunotherapy reach clinical and industrial stages.

Le Gouëllec A, Chauchet X, Polack B, Buffat L, Toussaint B.

Hum Vaccin Immunother. 2012 Oct;8(10):1454-8. doi: 10.4161/hv.21429. Epub 2012 Aug 16. Review.

39.

Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation.

Berthier S, Nguyen MV, Baillet A, Hograindleur MA, Paclet MH, Polack B, Morel F.

PLoS One. 2012;7(7):e40277. doi: 10.1371/journal.pone.0040277. Epub 2012 Jul 10.

40.

Gla-domainless factor Xa: molecular bait to bypass a blocked tenase complex.

Marlu R, Polack B.

Haematologica. 2012 Aug;97(8):1165-72. doi: 10.3324/haematol.2011.055699. Epub 2012 Apr 4.

41.

Optimization of antitumor immunotherapy mediated by type III secretion system-based live attenuated bacterial vectors.

Wang Y, Gouëllec AL, Chaker H, Asrih H, Polack B, Toussaint B.

J Immunother. 2012 Apr;35(3):223-34. doi: 10.1097/CJI.0b013e31824747e5.

PMID:
22421940
42.

Antithrombin-independent effects of heparins on fibrin clot nanostructure.

Yeromonahos C, Marlu R, Polack B, Caton F.

Arterioscler Thromb Vasc Biol. 2012 May;32(5):1320-4. doi: 10.1161/ATVBAHA.112.245308. Epub 2012 Feb 23.

PMID:
22362760
43.

Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.

Derouazi M, Wang Y, Marlu R, Epaulard O, Mayol JF, Pasqual N, Le Gouellec A, Polack B, Toussaint B.

Bioeng Bugs. 2010 Jan-Feb;1(1):51-60. doi: 10.4161/bbug.1.1.9482.

44.

Nanostructure of the fibrin clot.

Yeromonahos C, Polack B, Caton F.

Biophys J. 2010 Oct 6;99(7):2018-27. doi: 10.1016/j.bpj.2010.04.059.

45.

Is primary prophylaxis required in afibrinogenemia?

Polack B, Pouzol P, de Mazancourt P, Gay V, Hanss M.

Transfusion. 2010 Jun;50(6):1401-3. doi: 10.1111/j.1537-2995.2010.02612.x. No abstract available.

PMID:
20598104
46.

Factor v Leiden homozygous genotype and pregnancy outcomes.

Biron-Andréani C, Bauters A, Le Cam-Duchez V, Delahousse B, Lequerrec A, Dutrillaux F, Boinot C, Saladin-Thiron C, Polack B, Gruel Y, Morange PE; PROCARE-GEHT Group.

Obstet Gynecol. 2009 Dec;114(6):1249-53. doi: 10.1097/AOG.0b013e3181c2243d.

PMID:
19935026
47.

Platelet hyperactivity during exercise leading to iterative coronary stent thrombosis: clinical implications.

Ormezzano O, Polack B, Vanzetto G, Sahnoun M, Machecourt J.

J Thromb Thrombolysis. 2010 Jul;30(1):105-8. doi: 10.1007/s11239-009-0394-3.

PMID:
19760171
48.

Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives.

Tellier Z, André MH, Polack B.

Clin Rev Allergy Immunol. 2009 Oct;37(2):125-34. doi: 10.1007/s12016-009-8115-4. Review.

PMID:
19184560
49.

Should plasma homocysteine be used as a biomarker of venous thromboembolism? A case-control study.

Ducros V, Barro C, Yver J, Pernod G, Polack B, Carpentier P, Desruet MD, Bosson JL.

Clin Appl Thromb Hemost. 2009 Oct;15(5):517-22. doi: 10.1177/1076029608322548. Epub 2008 Sep 25.

PMID:
18818229
50.

Discordant D-dimer results of two rapid quantitative automated assays are related to age.

Barro C, Bosson JL, Satger B, Polack B, Pernod G.

J Thromb Haemost. 2008 Nov;6(11):1970-1. doi: 10.1111/j.1538-7836.2008.03149.x. Epub 2008 Aug 30. No abstract available.

Supplemental Content

Loading ...
Support Center